Background-Phytosterols are plant-derived sterols that are taken up from food and can serve as biomarkers of cholesterol uptake. Serum levels are under tight genetic control. We used a genomic approach to study the molecular regulation of serum phytosterol levels and potential links to coronary artery disease (CAD). Methods and Results-A genome-wide association study for serum phytosterols (campesterol, sitosterol, brassicasterol) was conducted in a population-based sample from KORA (Cooperative Research in the Region of Augsburg) (nϭ1495) with subsequent replication in 2 additional samples (nϭ1157 and nϭ1760). Replicated single-nucleotide polymorphisms (SNPs) were tested for association with premature CAD in a metaanalysis of 11 different samples comprising 13 764 CAD cases and 13 630 healthy controls. Genetic variants in the ATP-binding hemitransporter ABCG8 and at the blood group ABO locus were significantly associated with serum phytosterols. Effects in ABCG8 were independently related to SNPs rs4245791 and rs41360247 (combined Pϭ1.6ϫ10 Ϫ50 and 6.2ϫ10 Ϫ25 , respectively; nϭ4412). Serum campesterol was elevated 12% for each rs4245791 T-allele. The same allele was associated with 40% decreased hepatic ABCG8 mRNA expression (Pϭ0.009). Effects at the ABO locus were related to SNP rs657152 (combined Pϭ9.4ϫ10 Ϫ13 ). Alleles of ABCG8 and ABO associated with elevated phytosterol levels displayed significant associations with increased CAD risk (rs4245791 odds ratio, 1.10; 95% CI, 1.06 to 1.14; Pϭ2.2ϫ10 Ϫ6 ; rs657152 odds ratio, 1.13; 95% CI, 1.07 to 1.19; Pϭ9.4ϫ10 Ϫ6 ), whereas alleles at ABCG8 associated with reduced phytosterol levels were associated with reduced CAD risk (rs41360247 odds ratio, 0.84; 95% CI, 0.78 to 0.91; Pϭ1.3ϫ10 Ϫ5 ). Conclusion-Common variants in ABCG8 and ABO are strongly associated with serum phytosterol levels and show concordant and previously unknown associations with CAD. (Circ Cardiovasc Genet. 2010;3:331-339.)
P hytosterols, such as campesterol and sitosterol, are naturally occurring constituents of plants with close structural similarity to cholesterol. Mammals are unable to synthesize these substances, and thus, the diet is the only source of phytosterols, which are abundant in vegetables, nuts, fruits, and seeds. 1 An average western diet contains approximately 200 to 400 mg phytosterols of which Ͻ5% are absorbed. Excretion of phytosterols is mainly by the biliary route. 1 Because phytosterols are derived exclusively from dietary sources and taken up with cholesterol, these substances can serve as markers of cholesterol uptake.
Clinical Perspective on p 339
Supplementation of phytosterols in "functional foods" is widely used for their potential to lower cholesterol by interfering with intestinal cholesterol absorption. In humans, doses of 0.8 to 4.0 g daily reduce low-density lipoprotein (LDL) levels by 10% to 15%. 2 However, such food supplementation can raise the serum concentration of these sterols. For example, dietary supplementation with 1.1 g phytosterols per day doubled cholesterol normalized serum campesterol levels. 3 Despite their LDL-lowering effect, there is increasing concern that elevated serum phytosterol levels may inadvertently increase cardiovascular risk. 1 A recent study found that dietary supplementation with phytosterols not only increases serum levels of the respective sterols, but also affects atherogenesis in mice and leads to increased tissue sterol concentrations in sclerotic aortic valves of humans. 4 Evidence for a proatherogenic role of phytosterols also is documented in patients with sitosterolemia, a rare autosomal disease characterized by massive accumulation of phytosterols in serum and tissues, who subsequently develop severe premature atherosclerosis. 5 Moreover, some but not all epidemiological studies found an association of elevated serum phytosterol levels with coronary artery disease (CAD). 6 -8 Serum phytosterol levels are under strong genetic control, with heritability estimates of Ϸ80%. 9 Known proteins responsible for controlling serum phytosterol levels include Niemann-Pick C1 Like 1 and ATP-binding cassette hemitransporters G5 and G8 (ABCG5, ABCG8). Niemann-Pick C1 Like 1, a proposed drug target for ezetimibe, plays a role in the entry of sterols into enterocytes, 10 whereas ABCG5 and ABCG8 have been identified as the genes responsible for familial sitosterolemia and sterol excretion. 5 However, little is known about the genetic regulation of phytosterol serum levels in the general population and the association of phytosterol gene variants with CAD. Therefore, we pursued a genomic approach first to identify common genetic variants associated with phytosterol serum levels and subsequently to test whether these variants were associated with CAD.
Methods
A detailed description of methods is provided in the online-only Data Supplement.
Study Cohorts
The study design is shown in Figure 1 . The genome-wide association study was carried out in 1644 population-based subjects from the Cooperative Research in the Region of Augsburg (KORA) S3/F3 study of which 1495 had full phenotypic and genotypic data. 11 Replication was sought in 2 further population-based studies, that is, a second, independent sample of the KORA S3/F3 study of 1157 adults and of the CARdiovascular disease, Living and Ageing in Halle (CARLA) study of 1760 adults. 12 Additional replication was performed in 760 healthy blood donors aged 18 to 68 years. 13 The association of phytosterol SNPs with CAD was investigated in a metaanalysis of 11 different populations comprising 13 764 CAD cases and 13 630 healthy controls. Basic characteristics of these study populations are described in the online-only Data Supplement.
All studies were conducted in accordance with the principles of the Declaration of Helsinki and were approved by the respective local ethics committees. The use of human liver samples obtained from patients who underwent partial liver resection was approved by the Ethics Committee of the University of Leipzig (Leipzig, Germany) (registration number ). 14
Phenotyping
Serum levels of phytosterols (campesterol, sitosterol, and brassicasterol) and cholesterol were determined by liquid chromatography tandem mass spectrometry as previously described. 15
Genotyping
Single-nucleotide polymorphism (SNP) arrays in the KORA S3/F3 study and the Wellcome Trust Case-Control Consortium CAD study were performed with the Affymetrix GeneChip 500K Mapping Array Set, 16, 17 whereas the Affymetrix Genome Wide Human SNP Array 6.0 was used in the German Myocardial Infarction Family Study II. Genotyping of individual SNPs was performed using the iPlex single-base primer extension and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, 18 a melting curvebased method with a single fluorescently labeled probe on an ABI PRISM 7900 HT Sequence Detection System, 19 and TaqMan allelic discrimination.
Gene Expression Analysis
RNA was isolated from healthy-appearing segments of liver samples using the monophasic TRIzol reagent. Gene expression of ABCG5, ABCG8, and ␤-actin was determined in an ABI PRISM 7900 HT Sequence Detection System by TaqMan quantitative RT-PCR. 19 
Stages of Genotyping and Statistical Analysis

First Stage: Genome-Wide Association Study of KORA S3/F3
From 490 032 SNPs, 390 130 were selected based on stringent quality criteria (inclusion criteria for autosomal SNPs: call rate, Ն95%; minor allele frequency, Ն1%; P-values of exact Hardy-Weinberg equilibrium test, Ն10 Ϫ6 ). Campesterol, sitosterol, brassicasterol, and corresponding ratios normalized to total cholesterol concentrations as well as total cholesterol itself were log-transformed before analysis. Models of additive genetic effects and recessive minor allele effects were calculated adjusting for age, sex, and log(BMI). For detection of population stratification, we analyzed quantile-quantile plots for all these test statistics. Inflation factors ranged between 1.00063 and 1.012, indicating no relevant inflation of test statistics (online-only Data Supplement Figure I) . Adjustment for the first 3 principal components did not substantially change the identified associations, supporting the absence of significant bias caused by population stratification (online-only Data Supplement Table I ). In addition, we used multivariate ANOVA to calculate a summary statistic for the combination of both the total phytosterol concentration and the ratios of total phytosterol and total cholesterol concentration.
Second Stage: Validation in KORA S3/F3 Stage 2
We selected 68 SNPs for further validation in the remaining individuals of the KORA S3/F3 study (nϭ1157). These included the 65 top SNPs of the list of SNPs ordered by the minimum of the P values of all univariate phenotype associations. In addition, 3 SNPs located in ABCG8 were genotyped. These included SNP rs4245791, which had initially violated quality criteria (call rate and Hardy-Weinberg equilibrium) on the 500K Array Set due to misgenotyping, and the 2 coding SNPs rs11887534 (D19H) and rs4148217 (T400K) not present on the 500K Array Set with known associations with serum phytosterol levels. 9 SNPs were genotyped using the Sequenom assay. From the 68 initially selected SNPs, 9, including the 4 located in ABCG8 (rs41360247, rs4245791, rs11887534, and rs4148217) and 5 additional SNPs, showed PϽ0.01 in at least 1 of the test statistics in the second stage and were selected for the final replication step.
Third Stage: Validation in CARLA
The 9 SNPs selected in stage 2 were genotyped in nϭ1760 individuals with full phenotype and covariate information in the CARLA cohort. For association analyses, data were further adjusted for statin treatment. Five of the 9 SNPs selected in the second stage were finally validated with significance levels below Bonferroni-corrected thresholds in at least 1 of the test statistics. The set of validated SNPs again comprised all 4 SNPs in ABCG8 (rs41360247, rs4245791, rs11887534, and rs4148217) and 1 SNP in ABO (rs657152).
Fine Mapping and Haplotype Analysis in CARLA
For fine mapping of the ABCG5 and ABCG8 locus, we genotyped additional SNPs in the haplotype block containing the 4 SNPs validated in the third stage from HapMap, including flanking and known-coding SNPs in CARLA subjects. After phasing of the data, 20 we determined the allelic association for each haplotype. Finally, we determined the genetic association for the major haplotype variants determined by rs4952688 and rs11887534 using additive models.
Combined Analysis
We calculated a combined effect for the validated SNPs (rs41360247, rs4245791, and rs657152), which were genotyped in all 3 stages using regression models that also included cohort assignment variables.
DNA Sequencing of ABCG5 and ABCG8
DNA sequencing of the intergenic region of ABCG5 and ABCG8 and Ϸ6 kb of the flanking sequence was performed in DNA from 17 human liver samples using the primers described in the online-only Data Supplement Table II .
Analysis of Blood Groups
Blood groups were determined by standard immunologic testing in the cohort of blood donors and by genotyping in the CARLA cohort. Association analysis of blood groups was performed by comparing the sterol phenotypes between the blood group O and the pooled blood groups A, B, and AB.
Metaanalysis of Phytosterol-Related SNPs With CAD
Association of the identified variants in ABCG8 (rs41360247 and rs4245791) and ABO (rs657152) was performed in a metaanalysis of 11 studies comprising 13 764 CAD cases and 13 630 healthy controls. Cases and controls of the single studies were selected from the same geographic region. Studies were analyzed separately using logistic regression models of additive and recessive heritability. Combined effects were estimated using fixed and random effects models. Heterogeneity between studies was tested with Q statistics. No significant heterogeneities were found. Calculations were performed using the package meta of the R software suite. Combined test of Hardy-Weinberg equilibrium was performed with the help of a stratified test proposed by Troendle and Yu. 21
Results
Genome-Wide Study of Plasma Phytosterols and Replication
The initial genome-wide analysis using the Affymetrix 500K array identified 1 single association at the ABCG8 gene rs41360247, achieving genome-wide significance for phytosterol serum levels (Table) . One additional SNP, rs4245791, located 775 bp distal to rs41360247 was also highly significant but had to be excluded in the initial analysis due to quality problems (online-only Data Supplement Table III ). This SNP also achieved genome-wide significance after regenotyping with the Sequenom assay (Table) . A total of 68 SNPs (online-only Data Supplement Table III) were taken forward for validation in an additional 1157 subjects of the KORA S3/F3 study (onlineonly Data Supplement Table IV) , and 9 SNPs achieving a nominal significance of PϽ0.01 were taken forward for replication in 1760 subjects of the independent CARLA study (online-only Data Supplement Table IIV ).
Fine Mapping and Haplotype Analysis of ABCG5 and ABCG8
SNPs rs4245791 and rs41360247 at the ABCG8 locus were significantly associated in all 3 studies (online-only Data Supplement Table VI and Table) and were independent of each other (r 2 ϭ0.03) (online-only Data Supplement Table VII ). Fine mapping of the haplotype block in CARLA ( Figure 2 and online-only Data Supplement Table VIII ) revealed that rs41360247 was in close linkage disequilibrium (r 2 ϭ0.93) with coding SNP rs11887534 (D19H), which has been associated with phytosterol levels in previous studies and is known to affect protein structure. 9 In addition, SNP rs4952688 was identified by fine mapping as a proxy for rs4245791 (r 2 ϭ0.89) with the lowest P values of association of all SNPs used for fine mapping. Haplotype analyses of the ABCG8 locus indicated that the effects of rs11887534 (D19H) and rs4952688 on phytosterol level SNPs were additive (online-only Data Supplement Figure  II and online-only Data Supplement Tables IX and X) .
Association of ABCG5 and ABCG8 SNP rs4952688 With mRNA Expression
One possible mechanism for the association between SNP rs4952688 and serum phytosterol levels was by affecting expression levels of ABCG5 or ABCG8. To test this hypothesis, we determined mRNA levels of these genes in 57 patient samples of normal human liver tissue and observed significantly reduced mRNA expression levels of these 2 genes in association with the T allele of rs4952688 ( Figure 3 ) but not with rs41360247 or rs11887534 (D19H). Sequencing of the putative intergenic promoter region revealed no SNPs associated with expression levels, suggesting that the responsible variant resides outside this region (online-only Data Supplement Figure III ).
Association of Phytosterols With ABO Blood Groups
Another novel finding was that in addition to ABCG8, the ABO gene locus was consistently associated and achieved genome-wide significance for association with phytosterol levels in the combined analysis (online-only Data Supplement Table VI and Table) . The effect of the ABO gene SNP rs657152 on phytosterol levels was independent of the effects mediated by SNPs in the ABCG8 gene (online-only Data Supplement Table VII ). The explained variance of serum phytosterols by ABO and ABCG8 loci was Ϸ10% (onlineonly Data Supplement Table XI) . ABO codes for a polymorphic glycosyl-transferring enzyme responsible for the major blood groups. Our studies revealed that rs657152 was tightly linked with the blood group O 1 allele (online-only Data Supplement Figure IV) , coding for a protein devoid of glycosyltransferase activity. Genetic analysis of blood groups in CARLA and immunologic determination in an independent cohort of blood donors confirmed that the nonfunctional O allele was associated with decreased phytosterol serum levels (Figure 4 and online-only Data Supplement Tables XII  and XIII) .
Metaanalysis of Association of Identified Phytosterol SNPs With CAD Risk
Given the evidence suggesting that elevated phytosterol levels may increase the risk of atherosclerosis, we next tested the association of variants in ABCG8 (rs41360247 and rs4245791) and ABO (rs657152) with CAD, which was done in a metaanalysis of 11 different studies comprising 13 764 CAD cases and 13 630 healthy controls ( Figure 5 ). Detailed results for each study are presented in online-only Data Supple-ment Figure V and online-only Data Supplement Tables XIV to  XVI . We found that alleles associated with increased phytosterol levels were positively associated with increased probability of CAD, whereas alleles associated with reduced phytosterols were associated with reduced probability of CAD ( Figure 5 ). We also tested the effect of identified genetic variants on LDL cholesterol levels because recent studies have shown an association with SNPs in ABCG5 and ABCG8. 22, 23 The latter could be confirmed for ABCG8 rs41360247 and rs4245791. We also found an association of ABO (rs657152) with LDL cholesterol (online-only Data Supplement Figure VI ).
Discussion
Our genome-wide analysis and functional studies revealed that Ϸ10% of the variability of serum phytosterol levels in the normal population is explained by 3 variants found at the ABCG8 and ABO gene loci. Using this information, we investigated whether genetic variants affecting phytosterol levels also modulate the risk of CAD. We found that all 3 polymorphisms identified to be associated with phytosterols were independently associated with CAD. Polymorphisms associated with increased phytosterol serum levels were associated with an increased risk of CAD, whereas a polymorphism associated with decreased phytosterols was associated with decreased CAD risk. Thus, our approach using genome-wide analysis of the intermediate phenotype of serum phytosterols, which is as a maker of cholesterol homeostasis, led to the identification of 3 novel genetic variants that modulate CAD risk.
ABCG8 is a plausible candidate for affecting the inherited variability of serum phytosterol levels, given that the gene encodes the ABC hemitransporter that carries phytosterols into the bile. 1, 2, 5 Indeed, smaller studies previously reported an association between the coding variant D19H in this gene and serum phytosterols, 9 a finding that was confirmed by our data. D19H also was found to affect the susceptibility for cholesterol gallstone disease. 24 It was speculated that the 19H variant may increase the efficiency of sterol excretion into the bile lumen, causing hypersaturation of the bile and subsequently leading to gallstone formation. 25 Indeed, there are published data about an association between the D19H variant and serum cholesterol levels. 26, 27 Moreover, recent genome-wide studies identified an association of LDL cholesterol with proxies to D19H and the other ABCG8 variant rs4245791. 22, 23 This effect could be confirmed in the present study (online-only Data Supplement Figure VI) , albeit the association of D19H (and the other variants we identified) with serum cholesterol levels was only weak, and effects on phytosterols remained highly significant after normalization to cholesterol (Table) or adjustment to LDL cholesterol (online-only Data Supplement Table XVII) .
A novel finding of the present study was that a second genomic effect at the ABCG8 locus added independently to the association with serum phytosterol levels. This one was tagged by SNPs rs4952688 and rs4245791 and related to increased liver expression of ABCG5 and ABCG8 mRNAs. The parallel regulation of 2 genes suggested that rs4952688 and rs4245791 might be linked to a variant, which affects transcriptional activation. However, sequencing of 6 kb around the intergenic region revealed no obvious causative mutations, indicating that other factors outside this region might be responsible (online-only Data Supplement Figure  III ).
An unexpected finding was that the ABO blood group gene locus also affected serum phytosterol levels. The O allele, which leads to dysfunctional mutations devoid of glycosyltransferase activity, was associated with significantly reduced phytosterol concentrations. One may speculate that the addition of carbohydrate groups to oligosaccharide chains of proteins might either reduce the activity of proteins responsible for eliminating sterols or induce the activity of proteins responsible for sterol uptake. In this regard, it is of interest that both ABCG5 and ABCG8 undergo N-linked glycosylation. 28 However, the specific biological mechanism by which ABO alters phytosterol levels is unclear. 29 Interestingly, it has been previously reported that serum cholesterol levels are slightly, but consistently elevated in non-O subjects. 30, 31 In this regard, it is of interest that ABO also showed an association with serum total and LDL cholesterol levels in our analyses (online-only Data Supplement Figure VI and Table) .
Importantly, the genetic variants associated with serum phytosterols also were associated with risk of CAD. It should be emphasized that we only tested the associations of these variants with CAD after their strong association with phytosterol levels became apparent. Therefore, the significance levels achieved for the association of the variants with CAD can be considered to be reasonably definitive. Hence, the present study adds 3 variants to the evolving list of genetic markers of this common disease. 16, 32, 33 However, our data fall short to prove that these 2 associations are causally linked (ie, that the increase in CAD risk is functionally mediated by higher phytosterol serum levels) because the identified variants also had a concomitant effect on cholesterol levels. In this regard, it is of interest that early studies demonstrating an effect of ABO on cholesterol also showed a somewhat higher 5-year incidence of myocardial infarction in non-O carriers, even though these data were on the margin of statistical significance. 34 Association between non-O blood group carriership with myocardial infarction recently has been confirmed in a metaanalysis of predominantly retrospective studies comprising 8220 cases and 509 009 controls. 35 Historically, ABO has been one of the first-available genetically determined markers, and there are numerous reports of associations with various phenotypes. Some of these studies had small sample sizes and showed only modest statistical significance, adding to skepticism about these findings. However, it is of great interest that ABO has been associated recently in a number of hypothesis-free genome-wide associations with a diverse set of phenotypes, such as pancreatic cancer or plasma levels of intercellular adhesion molecule-1. 36, 37 These data suggest that ABO effects on these phenotypes may indeed underlie a common mechanism that still needs to be determined.
Despite that it is not clear from our study whether phytosterols or cholesterol are causally linked with CAD, our results provide evidence for a role of sterol homoestasis as an effector of CAD because phytosterols are well-established markers of sterol uptake and excretion. In this context, it should be mentioned that we observed additive effects of risk alleles from the 3 variants on both phenotypes. In addition, a mechanistic link between phytosterol serum levels and CAD risk cannot be excluded for several reasons. First, elevated phytosterol levels have been associated with CAD in previously published studies. 4, 6, 7, 38 Second, patients with sitosterolemia, a rare autosomal disease caused by mutations in ABCG5 and ABCG8, display a severe accumulation of phytosterols in serum and tissues and subsequently develop premature atherosclerosis. 5 Finally, deposits of plant sterols have been found in plaques and degenerated aortic valves of patients with atherosclerosis. 4, 39 Our findings might have potential public health relevance with regard to the frequent use of phytosterol food supplements because a substantial number of individuals with certain genotypes may respond with relatively high phytosterol serum levels after intake of these additives. 3 In summary, to our knowledge, this genome-wide association study is the first to investigate genetic variability of serum phytosterol levels in the general population. We identified significant associations of serum plant sterols with 3 functional genetic variants. Particularly, our data suggest novel additive mechanisms for ABCG8 and ABO in regulating serum phytosterol levels, which also have an impact on serum LDL cholesterol levels. Moreover, we show that common genetic variants associated with serum phytosterol levels affect CAD risk concordantly. These data show for the first time that genetic variants affecting sterol homeostasis play a role in susceptibility to CAD.
